Reporter David Evans noticed that big pharmaceuticals companies were paying heavier and heavier criminal fines for illegally marketing some of their best-selling drugs, and he wondered why they would keep breaking the law so blatantly. In "Big Pharma's Crime Spree," Evans reports that even when drug companies pay huge penalties they have little economic incentive to stop the illegal activity.
Judges' comments: Bloomberg Markets "Big Pharma's Crime Spree" brings out in the open the ongoing law-breaking by pharmaceutical companies in pursuit of profits. We loved reading the story behind the story and were impressed by the writer's ability to track down former lawbreakers and get them to talk.
Read "Big Pharma's Crime Spree."
See the contest questionnaire in which the reporter writes about how this story was written.